MedPath

Effects of Daily Supplementation of 5-HTP on Body Composition

Not Applicable
Completed
Conditions
Body Composition
Interventions
Other: Placebo
Dietary Supplement: 5-HTP
Registration Number
NCT05216406
Lead Sponsor
Nova Southeastern University
Brief Summary

The purpose of this investigation was to compare supplementation with 5-HTP to placebo on indices of body composition. A randomized trial compared a sample of 48 resistance-trained individuals taking either 100 mg of 5-hydroxytryptophan supplementation or a placebo.

The investigators tested anthropometric measurements using a multi-frequency bioelectrical impedance device (InBody® 270). The primary outcome (i.e., changes in anthropometric measurements) was assessed at the first visit (pre-test-) and post-test (8 weeks). Secondary outcomes include resting heart rate, blood pressure, and dietary intake.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
65
Inclusion Criteria
  • Healthy or free of disease
  • Minimum of 1 year of regular physical activity. Regular physical activity is defined by a minimum of 150 minutes of aerobic activity or performing muscle-strengthening exercises at least 2 days a week.
Exclusion Criteria
  • Physically inactive
  • Regularly used sleep aids of any kind
  • Currently taking selective serotonin reuptake inhibitors (SSRIs) and/or 5-HTP containing supplements.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ControlPlaceboThe placebo consisted of maltodextrin. Subjects were instructed to consume one capsule daily at their convenience for 8 weeks.
5-HTP5-HTPThe dietary supplement (100 mg of 5-hydroxytryptophan; CLEANMOOD™) was provided by NURA™ (Irvine, California USA). Subjects were instructed to consume one capsule daily at their convenience for 8 weeks.
Primary Outcome Measures
NameTimeMethod
Body Composition8 weeks

The percentage of fat, bone, and muscle was assessed pre and post visit using multi-frequency bioelectrical impedance device (InBody® 270).

Secondary Outcome Measures
NameTimeMethod
Blood Pressure8 weeks

Systolic and diastolic blood pressure will be measured during pre and post visit using an upper arm blood pressure monitor and cuff.

Resting Heart Rate8 weeks

Resting heart rate will be measured pre and post visit using an upper arm blood pressure monitor and cuff.

Dietary Habits8 weeks

The mobile app MyFitnessPal was used to assess dietary intake. Subjects were instructed to log their food intake MyFitnessPal, for a minimum of 2-3 days per week during the entire study.

Trial Locations

Locations (1)

IHP

🇺🇸

Boca Raton, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath